Afuco™ Anti-Human NGF ADCC Therapeutic Antibody (PG110), ADCC Enhanced
Anti-NGF ADCC Enhanced Antibody (PG110) is an ADCC enhanced antibody produced by our Afuco™ platform. PG110 is a monoclonal antibody that inhibits the effects of the naturally occurring substance, nerve growth factor (NGF). Phase I study to evaluate the safety, tolerability, and pharmacokinetics of PG110 (Anti-NGF Monoclonal Antibody) in patients with pain attributed to osteoarthritis of the knee.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-659CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | NGF |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | ELISA, Inhib, FuncS |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |